Understanding Investigational Product Accountability
Investigational Products (IPs) encompass pharmaceuticals, biologics, medical devices, and other interventions undergoing evaluation in clinical trials. IP accountability refers to the processes and protocols implemented to ensure the proper handling, administration, and documentation of investigational products throughout the course of a clinical trial. Key aspects of IP accountability include:
